Figure 4: Mechanism of nanocapsule formation and cell interaction. A major problem of the lipid formulations of cisplatin used so far, appears to be the low drug-to-lipid ratio, which limits the ...

Patients with squamous cell carcinoma of the head and neck were randomly assigned to receive either intensity-modulated radiotherapy with weekly cetuximab or radiotherapy alone.

To explore ways to overcome cancer cells' resistance to cisplatin, investigators from Cedars-Sinai, the University of Colorado Anschutz Medical Campus, and Erasmus University Medical Center ...

Researchers found that dual “off the shelf” stem cells designed to release an oncolytic virus and immune check point inhibitor improved survival in a model of leptomeningeal brain metastasis ...

Cisplatin, due to its high kinetic lability, fails to distinguish between healthy and cancer cells, leading to toxic side effects associated with its treatment. Carboplatin, which has a different ...

Phone calls to follow up with patients with locally advanced esophageal squamous cell carcinoma while at home may reduce AEs ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those ...

China-based Kelun-Biotech Biopharmaceutical has received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed ...

AstraZeneca has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for ...